Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Bioharvest Sciences (BHST) Loans and Notes Receivables (2023 - 2025)

Bioharvest Sciences has reported Loans and Notes Receivables over the past 3 years, most recently at $935000.0 for Q4 2025.

  • For Q4 2025, Loans and Notes Receivables rose 34.53% year-over-year to $935000.0; the TTM value through Dec 2025 reached $935000.0, up 34.53%, while the annual FY2025 figure was $935000.0, 34.53% up from the prior year.
  • Loans and Notes Receivables was $935000.0 for Q4 2025 at Bioharvest Sciences, down from $1.1 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $1.1 million in Q3 2025 and bottomed at $423000.0 in Q4 2023.
  • The 3-year median for Loans and Notes Receivables is $754000.0 (2025), against an average of $766555.6.
  • Year-over-year, Loans and Notes Receivables surged 64.3% in 2024 and then increased 8.49% in 2025.
  • Over 3 years, Loans and Notes Receivables stood at $423000.0 in 2023, then surged by 64.3% to $695000.0 in 2024, then soared by 34.53% to $935000.0 in 2025.
  • The last three reported values for Loans and Notes Receivables were $935000.0 (Q4 2025), $1.1 million (Q3 2025), and $858000.0 (Q2 2025) per Business Quant data.